Discussion HHV-6 is a new member of the herpes virus group.' The predominant affinity of CD4 positive T cells4 and a high incidence of latent infection with the virus suggest that HHV-6, like other such viruses, may cause specific lymphocyte related disease or may have some role in opportunistic infection. Recently, Josephs et al and Jarrett et al reported that HHV-6 DNA had been detected in three of 82 B cell lymphomas 8 and two of 117 lymphomas using Southern blot analysis. 7 Buchbinder et al and Torelli et al also reported detecting HHV-6 DNA in 23 of 25 different malignant lymphomas,9 three of 25 Hodgkin's lymphomas, and none of 41 nonHodgkin's lymphomas6 using PCR methods. A definite association between malignant lymphoma and HHV-6 however, was still unclear.
In our study we found amplified HHV-6 DNA using PCR in 50-0-68-8 % of samples studied, but found no clear differentiation in rates of detection among different types of malignant lymphoma. Using Southern blot analysis, we were unable to detect any HHV-6 DNA. Using PCR, Kondo et al identified infected monocyte/macrophage cells in lymphadenopathies. 10 We also clarified that HHV-6 infected CD68-positive monocyte/macrophage cells existed in a latent form, using double staining in situ hybridisation and immunohistochemistry methods." We therefore deduced that the presence of HHV-6 DNA shown by PCR in lymphoid malignancies was derived from latent infection. In this study we were unable to determine the HHV-6 positive cell subsets, but the HHV-6 positive cells might be infected in monocyte/macrophage cells as they are the same as in benign lymphadenitis. Clinical symptoms and manual haematocrits, performed by a spin technique, indicated that the patient was more anaemic than was suggested by the reported haemoglobin concentration. If the plasma from the sample was removed and replaced by an equal volume of Isoton, the measured haemoglobin was 40 g/l lower than first estimated. Treatment of the plasma with 2-mercaptoethanol (2ME) did not correct this discrepancy. No cryoglobulin could be detected.
Method and Results
The patient's plasma was separated from fresh EDTA samples, mixed with Coulter lysing solution (Lyse-S), and analysed through a Coulter STKR. The plasma treated in this way gave a "haemoglobin" estimation of 40 g/l, confirming that a plasma fraction was interacting with the lysing reagent to cause the false reading. The patient's plasma was then separated into IgG and IgM fractions using Quick-Sep columns, according to the manufacturer's protocol (Isolab Inc, Drawer 4350, Akron, Ohio, USA). As controls, plasma was obtained from a known IgG myeloma and from another patient with Waldenstrom's macroglobulinaemia in whom haemoglobin estimates were felt to be accurate and these were separated in the same way. The optical density (OD) of each fraction was then measured at 525 nm before and after the addition of Lyse-S at a 1 in 7 dilution. A sharp increase in OD of the test IgG fraction was seen. There was also a small increase in the OD of the IgG fraction from plasma from the control with Waldenstr6m's macroglobulinaemia but no change in the IgG myeloma control (table). A precipitate formed when the patient's gests that the difference may be one of degree; the more monomeric IgM formed, the greater the chance of detecting similar interactions. This would merit further assessment. In the case described, in order to obtain an accurate haemoglobin measurement for clinical use, all the plasma has to be removed from a spun EDTA sample. This is replaced with an equal volume of Isoton and the manipulated sample is then processed through the Coulter STKR in the normal manner.
